Literature DB >> 19656885

Analysis of human cytomegalovirus-encoded microRNA activity during infection.

Noam Stern-Ginossar1, Niveen Saleh, Miri D Goldberg, Mark Prichard, Dana G Wolf, Ofer Mandelboim.   

Abstract

MicroRNAs (miRNAs) are expressed in a wide variety of organisms, ranging from plants to animals, and are key posttranscriptional regulators of gene expression. Virally encoded miRNAs are unique in that they could potentially target both viral and host genes. Indeed, we have previously demonstrated that a human cytomegalovirus (HCMV)-encoded miRNA, miR-UL112, downregulates the expression of a host immune gene, MICB. Remarkably, it was shown that the same miRNA also downregulates immediate-early viral genes and that its ectopic expression resulted in reduced viral replication and viral titers. The targets for most of the viral miRNAs, and hence their functions, are still unknown. Here we demonstrate that miR-UL112 also targets the UL114 gene, and we present evidence that the reduction of UL114 by miR-UL112 reduces its activity as uracil DNA glycosylase but only minimally affects virus growth. In addition, we show that two additional HCMV-encoded miRNAs, miR-US25-1 and miR-US25-2, reduce the viral replication and DNA synthesis not only of HCMV but also of other viruses, suggesting that these two miRNAs target cellular genes that are essential for virus growth. Thus, we suggest that in addition to miR-UL112, two additional HCMV miRNAs control the life cycle of the virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656885      PMCID: PMC2753100          DOI: 10.1128/JVI.01292-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Enhanced recognition of human NK receptors after influenza virus infection.

Authors:  Hagit Achdout; Tal I Arnon; Gal Markel; Tsufit Gonen-Gross; Gil Katz; Niva Lieberman; Roi Gazit; Aviva Joseph; Eli Kedar; Ofer Mandelboim
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

2.  Identification of virus-encoded microRNAs.

Authors:  Sébastien Pfeffer; Mihaela Zavolan; Friedrich A Grässer; Minchen Chien; James J Russo; Jingyue Ju; Bino John; Anton J Enright; Debora Marks; Chris Sander; Thomas Tuschl
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

3.  Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Authors:  Michael Boeckh; MeeiLi Huang; James Ferrenberg; Terry Stevens-Ayers; Laurence Stensland; W Garrett Nichols; Lawrence Corey
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

4.  Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

Authors:  K Xu; H Ma; T J McCown; I M Verma; T Kafri
Journal:  Mol Ther       Date:  2001-01       Impact factor: 11.454

5.  Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication.

Authors:  C T Courcelle; J Courcelle; M N Prichard; E S Mocarski
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

7.  Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.

Authors:  Marc van de Wetering; Irma Oving; Vanesa Muncan; Menno Tjon Pon Fong; Helen Brantjes; Dik van Leenen; Frank C P Holstege; Thijn R Brummelkamp; Reuven Agami; Hans Clevers
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 8.  Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system.

Authors:  Edward S Mocarski
Journal:  Cell Microbiol       Date:  2004-08       Impact factor: 3.715

9.  Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients.

Authors:  Dana G Wolf; Nell S Lurain; Tsila Zuckerman; Ron Hoffman; Judith Satinger; Alik Honigman; Niveen Saleh; Emanuel S Robert; Jacob M Rowe; Zipora Kra-Oz
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

10.  Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Authors:  Claire Dunn; N Jan Chalupny; Claire L Sutherland; Stephanie Dosch; P V Sivakumar; David C Johnson; David Cosman
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  60 in total

Review 1.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

Review 2.  Viral miRNAs: tools for immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Curr Opin Microbiol       Date:  2010-06-25       Impact factor: 7.934

3.  Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.

Authors:  Meaghan H Hancock; Rebecca S Tirabassi; Jay A Nelson
Journal:  Virology       Date:  2012-02-02       Impact factor: 3.616

Review 4.  Viral miRNAs and immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Biochim Biophys Acta       Date:  2011-07-05

Review 5.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

6.  High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection.

Authors:  Thomas J Stark; Justin D Arnold; Deborah H Spector; Gene W Yeo
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 7.  Cytomegalovirus microRNAs.

Authors:  Lauren Hook; Meaghan Hancock; Igor Landais; Robert Grabski; William Britt; Jay A Nelson
Journal:  Curr Opin Virol       Date:  2014-04-23       Impact factor: 7.090

Review 8.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

9.  Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands.

Authors:  Lars Dölken; Astrid Krmpotic; Sheila Kothe; Lee Tuddenham; Mélanie Tanguy; Lisa Marcinowski; Zsolt Ruzsics; Naama Elefant; Yael Altuvia; Hanah Margalit; Ulrich H Koszinowski; Stipan Jonjic; Sébastien Pfeffer
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

10.  Human cytomegalovirus miR-US5-1 inhibits viral replication by targeting Geminin mRNA.

Authors:  Shujuan Jiang; Yujing Huang; Ying Qi; Rong He; Zhongyang Liu; Yanping Ma; Xin Guo; Yaozhong Shao; Zhengrong Sun; Qiang Ruan
Journal:  Virol Sin       Date:  2017-10-31       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.